All Articles

Lincah's acquisition of Orderfaz isn't just a merger; it's a strategic move to build the automated infrastructure for Southeast Asia's $100B social commerce boom.

A lawsuit and FDA rejection reveal a critical truth: for biotechs like Telix, innovation is nothing without a flawless supply chain. What does this mean for investors?

An award for a 20-year partnership between BAIC Foton and TÜV Rheinland reveals the hidden engine of global expansion: strategic certification.

A simple farmers' market booth is teaching underserved youth more than business basics; it's building a new model for economic empowerment in LA.

A new licensing deal for Dickies in Australia reveals a powerful strategy for revitalizing heritage brands through hyper-localized market expertise.

Buried by legacy claims, Asbestos Corporation navigates a complex cross-border bankruptcy. Who pays for survival when the parent company is first in line?

A minor FDA delay for a breakthrough dwarfism drug tests investor nerves. What does this mean for Ascendis Pharma and the future of rare disease therapy?

Naughty Chile Taqueria is betting on the birria trend, but its strategy reveals a larger shift in how consumers eat and how retail businesses can win.

Two landmark FDA approvals in late 2025 have transformed the outlook for mitochondrial myopathies, igniting a market poised for explosive growth.

A new supplement promises better oral health from within. We unpack its D2C strategy, unproven formula, and place in the booming wellness economy.

Amid a sales slump and a new interim CEO, CarMax's upcoming earnings call will be a critical test of its future strategy in a volatile used car market.

The US Navy is canceling frigate orders to fast-track a new hybrid fleet. See how Fincantieri is adapting, securing its future and reshaping US shipbuilding.

Behind every fine dining meal is a silent giant. C&S's bold moves reveal the future of our food supply and the hidden investments shaping it.

Capstone Green Energy secures $15M in a PIPE financing with heavy insider buying, targeting the booming AI and data center power market. A strategic pivot.

Director Lisa Davis's exit from Air Products' board leaves a key gap as the industrial giant pushes deeper into the competitive clean hydrogen market.

Starlight's U.S. real estate fund announces its final dissolution after forced asset sales, highlighting the harsh impact of high interest rates.

This biotech challenger has two potential blockbusters for obesity and liver disease. Is a multi-billion dollar acquisition the next step on its journey?

As Core & Main preps its Q3 results, investors seek clues on infrastructure spending, market health, and if the firm can navigate economic crosswinds.

Lower Q3 earnings hide a deeper story. Safe Bulkers is aggressively renewing its fleet and tapping green finance to navigate a volatile shipping market.

Shareholders greenlight a deal creating a major player in medium-duty electric trucks, signaling a new phase of consolidation for the EV industry.